Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Total Liabilities (Quarterly): 179.66M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 179.66M |
| March 31, 2024 | 180.45M |
| December 31, 2023 | 181.36M |
| September 30, 2023 | 185.78M |
| June 30, 2023 | 179.03M |
| March 31, 2023 | 182.41M |
| December 31, 2022 | 183.69M |
| September 30, 2022 | 200.94M |
| June 30, 2022 | 201.97M |
| March 31, 2022 | 193.04M |
| December 31, 2021 | 201.92M |
| September 30, 2021 | 181.25M |
| June 30, 2021 | 176.64M |
| March 31, 2021 | 161.89M |
| December 31, 2020 | 148.41M |
| September 30, 2020 | 180.95M |
| June 30, 2020 | 180.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 168.04M |
| December 31, 2019 | 165.10M |
| September 30, 2019 | 161.83M |
| June 30, 2019 | 144.88M |
| March 31, 2019 | 143.89M |
| December 31, 2018 | 116.64M |
| September 30, 2018 | 13.14M |
| June 30, 2018 | 16.75M |
| March 31, 2018 | 15.91M |
| December 31, 2017 | 157.28M |
| September 30, 2017 | 13.55M |
| June 30, 2017 | 10.94M |
| March 31, 2017 | 10.99M |
| December 31, 2016 | 11.33M |
| September 30, 2016 | 0.8526M |
| June 30, 2016 | 0.6097M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
148.41M
Minimum
Dec 2020
201.97M
Maximum
Jun 2022
180.70M
Average
180.95M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 237.87M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.16M |
| Shareholders Equity (Quarterly) | 263.50M |
| Debt to Equity Ratio | 0.2409 |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | 0.34% |